The present study found that there had been a marked reduction in benefits paid for vitamin D testing (Box). In absolute terms, there was a saving of about $39.46 million (an average fall of 42%) compared with the same time period the year before. The greatest fall occurred in the summer month of February 2015 but the trend continued in the winter months. The number of services for vitamin D per 100 000 population fell from 18 140 in 2013e14 to 14 415 in 2014e15. The savings to the end of the 2014e15 financial year equate to about $42 million and, if the trend continues (ie, a reduction of 42%), the annual savings will be close to $64 million, reducing the annual spend to $60 million.
The new policy has almost halved expenditure in a short period of time and, if sustainable, will result in a large amount of funds to be reinvested. Before this intervention there had been an unsustainable growth in vitamin D testing. This report highlights the impact of various strategies including analysis of general practitioner test-ordering patterns and quality use of pathology testing policy based on good clinical practice and evidence-based medicine. The report highlights the value of regular monitoring and publication of all high-cost and high-volume pathology test item numbers, which will allow professional societies as well as individual clinicians to monitor trend data to look for opportunities to reinvest the scarce health dollar. New realtime business intelligence and Big Data tools have made this task easier. 4 The study is limited by the nature of the MBS data, which capture only the number and dollar benefit of service. Further, patient-level data analysis could shed light on appropriateness of testing.
Although a large proportion of Australians (between 31% and 58%) are estimated to have vitamin D deficiency (defined as serum 25-hydroxyvitamin D levels < 50 nmol/L 5 ), according to season, moderate to severe deficiency is uncommon and only present in about 4% of people. 2, 6 The new testing requirements should allow better targeting of those at greatest risk and those who will benefit most. n 
